- Presentations
- 5
- Markets
- 1
Dyanavel XR is a brand of Amphetamine marketed by NextWave Pharmaceuticals, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Amphetamine
- Brand owner
- NextWave Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 2.5 mg/mL extended-release oral suspension, 10 mg extended-release tablet, 15 mg extended-release tablet, 20 mg extended-release tablet, 5 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Dyanavel XR 2.5 mg/mL extended-release oral suspensionOral | NextWave Pharmaceuticals | US FDA | Available on request |
| Dyanavel XR 10 mg extended-release tabletOral | NextWave Pharmaceuticals | US FDA | Available on request |
| Dyanavel XR 15 mg extended-release tabletOral | NextWave Pharmaceuticals | US FDA | Available on request |
| Dyanavel XR 20 mg extended-release tabletOral | NextWave Pharmaceuticals | US FDA | Available on request |
| Dyanavel XR 5 mg extended-release tabletOral | NextWave Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Amphetamine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Dyanavel XR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.